当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析

科伦药业

(002422)

  

流通市值:430.94亿  总市值:527.36亿
流通股本:13.06亿   总股本:15.98亿

科伦药业(002422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润12.45亿元,每股收益0.75元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2862286.80万元,未分配利润1180235.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产4010429.84万元,负债1148143.04万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入13,276,729,7639,083,327,6204,389,897,04521,812,414,489
营业总成本11,864,487,3737,818,465,9813,728,008,89217,850,873,646
其他经营收益
营业利润1,779,909,0671,513,437,194793,737,6894,426,321,461
利润总额1,648,930,0821,417,649,449773,184,7024,285,358,824
净利润1,244,770,5181,113,856,403659,587,4763,361,954,393
每股收益
其他综合收益-43,268,342-39,588,443-6,264,06611,139,131
综合收益总额1,201,502,1761,074,267,960653,323,4103,373,093,524
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计20,505,152,41719,583,664,73718,489,123,74217,935,981,250
非流动资产:
非流动资产合计19,599,146,01119,466,837,70019,337,105,13919,380,278,232
资产总计40,104,298,42839,050,502,43737,826,228,88137,316,259,482
流动负债:
流动负债合计10,157,762,7449,075,838,5909,092,533,2329,137,877,768
非流动负债:
非流动负债合计1,323,667,6591,309,657,8311,302,768,9461,440,199,641
负债合计11,481,430,40310,385,496,42110,395,302,17810,578,077,409
所有者权益(或股东权益):
归属于母公司股东权益合计23,707,836,19523,679,226,04123,094,459,07822,479,520,446
股东权益合计28,622,868,02528,665,006,01627,430,926,70326,738,182,073
负债和股东权益合计40,104,298,42839,050,502,43737,826,228,88137,316,259,482
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计16,046,074,51610,728,655,7825,184,117,25325,767,456,082
经营活动现金流出小计14,361,632,1849,539,120,9054,734,733,00921,274,594,238
经营活动产生的现金流量净额1,684,442,3321,189,534,877449,384,2444,492,861,844
投资活动产生的现金流量:
投资活动现金流入小计20,383,103,84812,803,165,5084,018,350,90811,317,443,464
投资活动现金流出小计21,766,266,51013,331,669,6274,708,422,26813,136,811,455
投资活动产生的现金流量净额-1,383,162,662-528,504,119-690,071,360-1,819,367,991
筹资活动产生的现金流量:
筹资活动现金流入小计6,181,756,8593,819,952,5411,430,590,9955,621,292,545
筹资活动现金流出小计4,104,803,5522,651,968,4291,063,394,1728,925,568,651
筹资活动产生的现金流量净额2,076,953,3071,167,984,112367,196,823-3,304,276,106
汇率变动对现金及现金等价物的影响-8,625,875-2,186,9653,846,622-12,779,820
现金及现金等价物净增加额2,369,607,1021,826,827,905130,356,329-643,562,073
期末现金及现金等价物余额6,314,369,1765,771,589,9794,075,118,4033,944,762,074
补充资料:
现金及现金等价物的净增加额-1,826,827,905--643,562,073
最新报告期:2025-11-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券李梦园1.331.601.792025-11-15
兴业证券孙媛媛0.931.211.432025-11-07
中国银河孙怡,程培0.931.251.462025-10-31
西南证券杜向阳0.981.281.512025-10-31
TOP↑